<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01148277</url>
  </required_header>
  <id_info>
    <org_study_id>Propofol vs Midazolam</org_study_id>
    <nct_id>NCT01148277</nct_id>
  </id_info>
  <brief_title>Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B</brief_title>
  <official_title>Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziv Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziv Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized-controlled trial (RCT) comparing the use of Propofol and
      Remifentanyl and traditional sedation (Midazolam and Fentanyl) for diagnostic colonoscopies
      in patients with compensated cirrhosis child A-B. The working hypothesis is that the use of
      propofol will be translated in a shorter recovery and discharge times with a higher patient
      satisfaction and a decrease in general complications (Hepatic Encephalopathy) in the context
      of patients with advanced liver disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">February 2012</completion_date>
  <primary_completion_date type="Anticipated">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and efficacy of propofol in liver diseases</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>At the end of each endoscopy</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Liver Disease</condition>
  <arm_group>
    <arm_group_label>Propofol and Remifentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol, colonoscopies, liver diseases, cirrhosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>midazolam and fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>midazolam and fentanyl, colonoscopies, liver diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control midazolam anf fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>midazolam anf fentanyl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol and Remifentnyl</intervention_name>
    <description>Intervention group (Propofol and remifentanyl): It will be administered under direct gastroenterologists' and hepatologist</description>
    <arm_group_label>Propofol and Remifentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam and fentanyl</intervention_name>
    <description>Intervention group (Propofol and fentanyl ): It will be administered under direct gastroenterologists'and hepatologist</description>
    <arm_group_label>midazolam and fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam anf fentanyl</intervention_name>
    <description>group (Midazolam with Fentanyl): Both drugs will be administered by the gastroenterologists and/ or hepatologist and/ or anesthiologist</description>
    <arm_group_label>control midazolam anf fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients older than 18 and younger than 75 years with cirrhosis defined by
             the presence of liver fibrosis at least F3 and higher in the METAVIR score or with
             established cirrhosis (Child Pugh A, B)

        Exclusion Criteria:

          -  Patients with significant cardiorespiratory disease i.e. advanced respiratory, renal
             and heart failure (ASA class III or higher except for patients with decompensate liver
             cirrhosis), obstructive sleep apnea.

          -  HCC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Assy Nimer, MD</last_name>
    <phone>+97246828445</phone>
    <email>ASSY.N@ZIV.HEALTH.GOV.IL</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ziv medical center liver unit</name>
      <address>
        <city>Safed, Israel</city>
        <zip>13100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nimer Assy, MD</last_name>
      <phone>+972-46828445</phone>
      <email>assy.n@ziv.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2010</study_first_submitted>
  <study_first_submitted_qc>June 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2010</study_first_posted>
  <last_update_submitted>April 5, 2011</last_update_submitted>
  <last_update_submitted_qc>April 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Liver Clinic</name_title>
    <organization>Ziv medical center</organization>
  </responsible_party>
  <keyword>Endoscopies</keyword>
  <keyword>Liver diseases</keyword>
  <keyword>Propofol</keyword>
  <keyword>Midazolam and remifentanyl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

